In the Press
January 26, 2023

UK Biotech Financing Report 2022 (UK BioIndustry Association)

The UK's innovative life sciences and biotech sector secured its fifth best fundraising year ever in 2022, with £1,785 million raised by UK-headquartered public and private companies across the year. While positive, this overall figure masks a mixed picture for the sector. Capital Markets partner Ariel White-Tsimikalis shares her thoughts on the state of UK IPOs in BIA’s UK Biotech Financing Report 2022. “London currently has the unique opportunity to attract mid-sized UK and European-based biotechs and other life sciences companies who are too big for a listing in mainland Europe but potentially too small for Nasdaq,” said, White-Tsimikalis. “With sharpened regulatory and political focus on bringing more growth capital to the UK markets and more companies successfully using AIM as a stepping stone to Nasdaq and the Main Market, London needs to present itself as a viable alternative destination for biotechs.”